Cargando…
The challenges of COVID‐19 Delta variant: Prevention and vaccine development
Several SARS‐CoV‐2 variants have emerged since the pandemic, bringing about a renewed threat to the public. Delta variant (B.1.617.2) was first detected in October 2020 in India and was characterized as variants of concern (VOC) by WHO on May 11, 2021. Delta variant rapidly outcompeted other variant...
Autores principales: | He, Xuemei, He, Cai, Hong, Weiqi, Zhang, Kang, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661803/ https://www.ncbi.nlm.nih.gov/pubmed/34909755 http://dx.doi.org/10.1002/mco2.95 |
Ejemplares similares
-
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021) -
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
por: Ao, Danyi, et al.
Publicado: (2023) -
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
por: Zhou, Weilin, et al.
Publicado: (2021) -
COVID‐19 Vaccination and Obesity: Optimism and Challenges
por: Townsend, Matthew J., et al.
Publicado: (2021) -
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)